REQUEST A DEMO
Total
USD $0.00
Search more companies

Urolaser Kennedy S.A. (Ecuador)

Main Activities: General Medical and Surgical Hospitals
Full name: Urolaser Kennedy S.A. Profile Updated: February 10, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Urolaser Kennedy S.A. is based in Ecuador. The head office is in Guayaquil. The company operates in the General Medical and Surgical Hospitals industry. It was established on March 26, 2009. 4 (2024) employees currently work for Urolaser Kennedy S.A.. The latest financial highlights indicate a net sales revenue drop of 15.81% in 2024. Over the same period, its total assets decreased by 6.88%. The enterprise’s net profit margin decreased by 2.88% in 2024.

Headquarters
Av. San Jorge 805, Clinica Kennedy Seccion Alfa Bldg. , Floor 5
Guayaquil; Guayas;

Contact Details: Purchase the Urolaser Kennedy S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Urolaser Kennedy S.A. report to view the information.
Registered Capital:
Purchase the Urolaser Kennedy S.A. report to view the information.
Financial Auditors:
Purchase the Urolaser Kennedy S.A. report to view the information.
Incorporation Date:
March 26, 2009
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
46%
Purchase this report to view the information.
44%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Urolaser Kennedy S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-15.81%
Total operating revenue
-15.81%
Operating profit (EBIT)
-14.63%
EBITDA
14.35%
Net Profit (Loss) for the Period
-25.33%
Total Assets
-6.88%
Total Equity
13.28%
Operating Profit Margin (ROS)
0.45%
Net Profit Margin
-2.88%
Return on Equity (ROE)
-6.06%
Quick Ratio
2.92%
Cash Ratio
0.97%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?